Case number 2024-1658
United Therapeutics Corporation v. Liquidia Technologies, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 13, 2024 | 0 | UNITED THERAPEUTICS CORPORATION v. LIQUIDIA TECHNOLOGIES, INC. [ORDER] [nonprecedential] (0) |
| Sep 3, 2024 | 50 | Submitted after ORAL ARGUMENT to Panel: Prost, Circuit Judge; Hughes, Circuit Judge and Cunningham, Circuit Judge.Arguing counsel: Douglas H. Carsten for United Therapeutics Corporation and Sanya Sukduang for Liquidia Technologies, Inc.Oral Argument Audio available here. [1029619] [MJL] [Entered: 09/03/2024 05:01 PM] (0) |
| Aug 30, 2024 | 49 | Entry of Appearance for Rachel Preston as counsel for Appellee Liquidia Technologies, Inc.. Service: 08/28/2024 by email. [1029211] [MVH] [Entered: 08/30/2024 02:11 PM] (1) |
| Aug 30, 2024 | 48 | ORDER filed granting motion leave to appear as counsel [46] filed by Appellee Liquidia Technologies, Inc. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [1029209] [MVH] [Entered: 08/30/2024 02:10 PM] (2) |
| Aug 29, 2024 | 47 | Letter from Appellant United Therapeutics Corporation.. Service: 08/29/2024 by email. [1028991] [24-1658] [Douglas Carsten] [Entered: 08/29/2024 07:24 PM] (50) |
| Aug 28, 2024 | 46 | MOTION of Appellee Liquidia Technologies, Inc. for leave to file entry of appearance for Rachel Preston. Service: 08/28/2024 by email. [1028629] [24-1658] [Sanya Sukduang] [Entered: 08/28/2024 06:03 PM] (6) |
| Aug 27, 2024 | 45 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Liquidia Technologies, Inc., Entry of Appearance [44], is not in compliance with the rules of this court (see attached). Compliant document due on 09/04/2024. Service as of this date by the Clerk of Court. [1028074] [MVH] [Entered: 08/27/2024 03:51 PM] (1) |
| Aug 27, 2024 | 44 | Entry of Appearance for Rachel Preston as counsel for Appellee Liquidia Technologies, Inc.. Service: 08/27/2024 by email. [1028025] [24-1658]. This document is non-compliant. See Doc. No. [45] [Rachel Preston] [Entered: 08/27/2024 03:02 PM] (1) |
| Aug 7, 2024 | 43 | Letter for Appellant United Therapeutics Corporation. Service: 08/07/2024 by email. [1023464] [24-1658]--[Edited 08/08/2024 by MVH] [Douglas Carsten] [Entered: 08/07/2024 03:46 PM] (49) |
| Aug 1, 2024 | 42 | Response to notice of oral argument from Appellant United Therapeutics Corporation. Service: 08/01/2024 by email. [1022277] [24-1658] [Douglas Carsten] [Entered: 08/01/2024 06:20 PM] (1) |
| Jul 22, 2024 | 41 | Response to notice of oral argument from Appellee Liquidia Technologies, Inc.. Service: 07/22/2024 by email. [1019433] [24-1658] [Sanya Sukduang] [Entered: 07/22/2024 10:47 AM] (1) |
| Jul 19, 2024 | 40 | NOTICE OF ORAL ARGUMENT. Panel: 2409C. Case scheduled September 3, 2024. Response to Notice of Oral Argument due: 08/02/2024. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [1019177] [MJL] [Entered: 07/19/2024 03:24 PM] (2) |
| Jul 18, 2024 | 39 | The following conflict dates submitted by Sanya Sukduang for Liquidia Technologies, Inc. have been accepted by the court: 09/05/2024, 09/06/2024. [1018865] [MJL] [Entered: 07/18/2024 01:31 PM] (0) |
| Jul 18, 2024 | 38 | **TEXT ONLY** ORDER granting motion to withdraw attorney Brittany Cazakoff [37] filed by Appellee Liquidia Technologies, Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [1018850] [JSP] [Entered: 07/18/2024 01:24 PM] (0) |
| Jul 16, 2024 | 37 | MOTION of Appellee Liquidia Technologies, Inc. to withdraw counsel Brittany Cazakoff. Service: 07/16/2024 by email. [1018263] [24-1658] [Sanya Sukduang] [Entered: 07/16/2024 03:24 PM] (7) |
| Jul 16, 2024 | 36 | Notice from Appellee Liquidia Technologies, Inc. regarding conflicts with oral argument. Service: 07/16/2024 by email. [1018262] [24-1658] [Sanya Sukduang] [Entered: 07/16/2024 03:21 PM] (3) |
| Jul 16, 2024 | 35 | 7 paper copies of Doc. No. [25] received from Liquidia Technologies, Inc. [1018234] [MJL] [Entered: 07/16/2024 02:43 PM] (0) |
| Jul 15, 2024 | 34 | 6 paper copies of Doc. No. [27] received from United Therapeutics Corporation. (Night Box). [1018233] [MJL] [Entered: 07/16/2024 02:42 PM] (0) |
| Jul 12, 2024 | 33 | Notice from Appellant United Therapeutics Corporation regarding conflicts with oral argument. Service: 07/12/2024 by email. [1017426] [24-1658] [Douglas Carsten] [Entered: 07/12/2024 02:15 PM] (2) |
| Jul 12, 2024 | 32 | NOTICE OF NON-COMPLIANCE: The paper copies (Doc. No. [31]) provided by Liquidia Technologies, Inc. are not in compliance with the rules of this court (see attached). Corrected paper copies are due within 5 business days. Service as of this date by the Clerk of Court. [1017423] [VDW] [Entered: 07/12/2024 02:11 PM] (2) |
| Jul 12, 2024 | 31 | 6 paper copies of Doc. No. [25] received from Appellee Liquidia Technologies, Inc.. [1017419]. These paper copies are non-compliant. See Doc. No. [32] [VDW] [Entered: 07/12/2024 02:08 PM] (0) |
| Jul 12, 2024 | 30 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [1017272] [GWK] [Entered: 07/12/2024 10:07 AM] (1) |
| Jul 11, 2024 | 29 | 6 paper copies of Doc. No. [26], [24] received from Appellant United Therapeutics Corporation. [1017254] [VDW] [Entered: 07/12/2024 09:05 AM] (0) |
| Jul 11, 2024 | 28 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellant United Therapeutics Corporation. Service: 07/11/2024 by email. [1017184] [24-1658] [Douglas Carsten] [Entered: 07/11/2024 04:27 PM] (3) |
| Jul 11, 2024 | 27 | MODIFIED ENTRY: APPENDIX FILED by Appellant United Therapeutics Corporation. Service: 07/11/2024 by email. [1017177] --[Edited 07/12/2024 by GWK - Reason: compliance review complete] Paper copies of the appendix must be submitted within submitted within five business days from the date of this notice. See Fed. Cir. R. 25(c)(3)(A). [Douglas Carsten] [Entered: 07/11/2024 04:25 PM] (668) |
| Jul 8, 2024 | 26 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant United Therapeutics Corporation. Service: 07/08/2024 by email. [1016233] --[Edited 07/10/2024 by GWK to request paper copies - compliance review complete] Paper copies of the reply brief must be submitted within submitted within five business days from the date of this notice. See Fed. Cir. R. 25(c)(3)(A). [Douglas Carsten] [Entered: 07/08/2024 09:15 PM] (41) |
| Jun 24, 2024 | 25 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellee Liquidia Technologies, Inc. Service: 06/24/2024 by email. [1012980] --[Edited 07/10/2024 by GWK to request paper copies - compliance review complete] Paper copies of the response brief must be submitted within submitted within five business days from the date of this notice. See Fed. Cir. R. 25(c)(3)(A). [Sanya Sukduang] [Entered: 06/24/2024 04:08 PM] (46) |
| Jun 18, 2024 | 24 | MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED by Appellant United Therapeutics Corporation. Service: 06/18/2024 by email. [1011915]--[Edited 07/10/2024 by GWK to request paper copies - compliance review complete] Paper copies of the corrected opening brief must be submitted within submitted within five business days from the date of this notice. See Fed. Cir. R. 25(c)(3)(A). [Douglas Carsten] [Entered: 06/18/2024 04:38 PM] (161) |
| Jun 18, 2024 | 23 | Notice of Correction to Doc No. [18] for Appellant United Therapeutics Corporation. Service: 06/18/2024 by email. [1011909] [24-1658] [Douglas Carsten] [Entered: 06/18/2024 04:32 PM] (4) |
| Jun 13, 2024 | 22 | ORDER filed granting ECF No. 17 only to the extent that the parties may include the documents identified in Exhibits 1-4 of ECF No. 17 in the appendix and cite the materials in the briefs. The relevance, if any, of the materials is left to the merits panel assigned to this appeal. Within seven days from the date of filing of this order, United Therapeutics is directed to file a corrected opening brief that cites to the documents within the appendix rather than as exhibits to ECF No. 17. The Clerk of Court shall transmit a copy of this order to the merits panel. Service as of this date by the Clerk of Court. [1010817] [LMS] [Entered: 06/13/2024 10:25 AM] (2) |
| May 28, 2024 | 21 | REPLY of Appellant United Therapeutics Corporation to response [20]. Service: 05/28/2024 by email. [1007012] [24-1658] [Douglas Carsten] [Entered: 05/28/2024 10:03 PM] (43) |
| May 23, 2024 | 20 | RESPONSE of Appellee Liquidia Technologies, Inc. to Doc No. [17]. Service: 05/23/2024 by email. [1006200] [24-1658] [Sanya Sukduang] [Entered: 05/23/2024 02:59 PM] (11) |
| May 16, 2024 | 19 | ORDER Any opposition to the motion, ECF No. 17, is due within seven days from the date of entry of this order. Any reply in support of the motion is due within three days thereafter. Service as of this date by the Clerk of Court. [1004669] [LMS] [Entered: 05/16/2024 02:09 PM] (2) |
| May 15, 2024 | 18 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellant United Therapeutics Corporation. Service: 05/15/2024 by email. [1004512] --[Edited 05/17/2024 by GWK - compliance review complete] This document has been corrected. See Doc No. [24] [Douglas Carsten] [Entered: 05/15/2024 11:24 PM] (161) |
| May 15, 2024 | 17 | MOTION of Appellant United Therapeutics Corporation to take judicial notice. Service: 05/15/2024 by email. [1004503] [24-1658] [Douglas Carsten] [Entered: 05/15/2024 10:03 PM] (31) |
| May 9, 2024 | 16 | ORDER The motion [10] is denied with respect to the request to stay and granted with respect to the request to expedite only to the extent provided in this order. (Per Curiam). Service as of this date by the Clerk of Court. [1003287] [NL] [Entered: 05/09/2024 03:36 PM] (2) |
| Apr 29, 2024 | 15 | REPLY of Appellant United Therapeutics Corporation to response [13]. Service: 04/29/2024 by email. [1000794] [24-1658] [Douglas Carsten] [Entered: 04/29/2024 10:39 PM] (21) |
| Apr 26, 2024 | 14 | Confidential Opposition to Motion for a Stay Pending Appeal and Expedite Appeal filed by Appellee Liquidia Technologies, Inc. corresponding to Doc. No. [13]. Service: 04/26/2024 by email. [1000464] [24-1658] [Sanya Sukduang] [Entered: 04/26/2024 10:12 PM] (0) |
| Apr 26, 2024 | 13 | RESPONSE of Appellee Liquidia Technologies, Inc. to Doc No. [10]. Service: 04/26/2024 by email. [1000463] [24-1658] [Sanya Sukduang] [Entered: 04/26/2024 10:06 PM] (375) |
| Apr 19, 2024 | 12 | ORDER Liquidia Technologies, Inc. is directed to respond to the motion [10] no later than 04/26/2024. Any reply is due no later than 04/29/2024. United Therapeutics's opening brief is due no later than 05/15/2024. (Per Curiam). Service as of this date by the Clerk of Court. [998918] [NL] [Entered: 04/19/2024 03:54 PM] (2) |
| Apr 18, 2024 | 11 | Confidential Appellant's Opposed Motion for a Stay Pending Appeal and to Expedite Appeal filed by Appellant United Therapeutics Corporation corresponding to Doc. No. [10]. Service: 04/18/2024 by email. [998687] [24-1658] [Douglas Carsten] [Entered: 04/18/2024 09:51 PM] (0) |
| Apr 18, 2024 | 10 | MOTION of Appellant United Therapeutics Corporation for an emergency stay pending appeal under Rule 8/18. Service: 04/18/2024 by email. [998686] [24-1658] [Douglas Carsten] [Entered: 04/18/2024 09:47 PM] (172) |
| Apr 18, 2024 | 9 | Docketing Statement for the Appellee Liquidia Technologies, Inc.. Service: 04/18/2024 by email. [998676] [24-1658] [Sanya Sukduang] [Entered: 04/18/2024 06:06 PM] (2) |
| Apr 18, 2024 | 8 | Notice of Related Case Information for Appellee Liquidia Technologies, Inc.. Service: 04/18/2024 by email. [998675] [24-1658] [Sanya Sukduang] [Entered: 04/18/2024 06:00 PM] (3) |
| Apr 18, 2024 | 7 | Certificate of Interest for Appellee Liquidia Technologies, Inc.. Service: 04/18/2024 by email. [998674] [24-1658] [Sanya Sukduang] [Entered: 04/18/2024 05:58 PM] (3) |
| Apr 18, 2024 | 6 | Entry of Appearance for Sanya Sukduang; Jonathan R. Davies; Brittany Cazakoff as counsel for Appellee Liquidia Technologies, Inc.. Service: 04/18/2024 by email. [998672] [24-1658] [Sanya Sukduang] [Entered: 04/18/2024 05:57 PM] (2) |
| Apr 18, 2024 | 5 | Docketing Statement for the Appellant United Therapeutics Corporation. Service: 04/18/2024 by email. [998671] [24-1658] [Douglas Carsten] [Entered: 04/18/2024 05:57 PM] (2) |
| Apr 17, 2024 | 4 | Notice of Related Case Information for Appellant United Therapeutics Corporation. Service: 04/17/2024 by email. [998281] [24-1658] [Douglas Carsten] [Entered: 04/17/2024 04:40 PM] (2) |
| Apr 17, 2024 | 3 | Certificate of Interest for Appellant United Therapeutics Corporation. Service: 04/17/2024 by email. [998276] [24-1658] [Douglas Carsten] [Entered: 04/17/2024 04:37 PM] (4) |
| Apr 17, 2024 | 2 | Entry of Appearance for Douglas H. Carsten; William Covington Jackson; Brian T. Burgess; Gerard J. Cedrone; William M. Jay; Shaun R. Snader; Adam Burrowbridge; Arthur P. Dykhuis as counsel for Appellant United Therapeutics Corporation. Service: 04/17/2024 by email. [998272] [24-1658] [Douglas Carsten] [Entered: 04/17/2024 04:36 PM] (3) |
| Apr 5, 2024 | 1 | Appeal docketed. Received: 04/02/2024. [995525]Entry of Appearance is due on 04/19/2024. Certificate of Interest is due on 04/19/2024. Docketing Statement is due on 04/19/2024. Appellant's brief is due on 06/04/2024. [ALK] [Entered: 04/05/2024 03:41 PM] (45) |
